Oramed Pharmaceuticals (STU:OJU1) Ending Cash Position : €51.97 Mil (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Oramed Pharmaceuticals Ending Cash Position?

Oramed Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was €51.97 Mil.

Oramed Pharmaceuticals's quarterly Ending Cash Position declined from Jun. 2024 (€78.74 Mil) to Sep. 2024 (€37.94 Mil) but then increased from Sep. 2024 (€37.94 Mil) to Dec. 2024 (€51.97 Mil).

Oramed Pharmaceuticals's annual Ending Cash Position declined from Dec. 2022 (€38.20 Mil) to Dec. 2023 (€8.30 Mil) but then increased from Dec. 2023 (€8.30 Mil) to Dec. 2024 (€51.97 Mil).

Oramed Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Oramed Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Ending Cash Position Chart

Oramed Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

16.31

65.66

38.20

8.30

51.97

Oramed Pharmaceuticals Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															8.30	17.09	78.74	37.94	51.97

Oramed Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Oramed Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	8.647	+	43.324
	=	51.97

Oramed Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	40.209	+	11.762
	=	51.97

Oramed Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Oramed Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (STU:OJU1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

ORMP:USA ORMP:Israel OJU1:Germany

Address

1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036

Website

https://www.oramed.com

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Oramed Pharmaceuticals Headlines

No Headlines